Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone
To access this article, please choose from the options below
Received May 2006; received in revised form September 2006; accepted October 2006.
PII: S1538-4721(08)00609-0
doi:10.1016/j.brachy.2008.08.004
© 2008 Published by Elsevier Inc.
